Skip to main content

Table 3 Treatment modalities, stratified by NCCN risk group, of men with PCa in the study region, metropolitan Melbourne and the rest of Victoria

From: Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia

NNCCN Risk group Low* Intermediate* High* Very high/Metastatic*
  Study region, n (%) Metropolitan, n (%) Rest of Victoria, n (%) Study region, n (%) Metropolitan, n (%) Rest of Victoria, n (%) Study region, n (%) Metropolitan, n (%) Rest of Victoria, n (%) Study region, n (%) Metropolitan, n (%) Rest of Victoria, n (%)
No treatment/AS/WW 46 (63.0 %) 244 (51.0 %) 337 (37.0 %) 36 (31.9 %) 161 (15.1 %) 201 (10.7 %) 8 (8.2 %) 45 (7.3 %) 44 (5.1 %) 1 (2.3 %) 4 (3.0 %) 3 (1.2 %)
Surgery (Prostatectomy) 14 (19.2 %) 142 (29.7 %) 400 (43.9 %) 31 (27.4 %) 543 (51.0 %) 1,104 (58.5 %) 13 (13.4 %) 168 (27.3 %) 313 (36.1 %) 2 (4.5 %) 9 (6.8 %) 21 (8.6 %)
EBRT/EBRT + HDR 5 (6.8 %) 33 (6.9 %) 56 (6.1 %) 23 (10.4 %) 161 (15.1 %) 345 (18.3 %) 35 (36.1 %) 233 (37.8 %) 311 (35.9 %) 11 (25.0 %) 60 (45.1 %) 109 (44.5 %)
EBRT + Surgery 1 (1.4 %) 5 (1.0 %) 26 (2.9 %) 3 (2.7 %) 78 (7.3 %) 108 (5.7 %) 5 (5.2 %) 60 (9.7 %) 96 (11.1 %) 0 (0.0 %) 6 (4.5 %) 9 (3.7 %)
LDR 5 (6.8 %) 22 (4.6 %) 69 (7.6 %) 7 (6.2 %) 53 (5.0 %) 68 (3.6 %) 0 (0.0 %) 0 (0.0 %) 1 (0.1 %) 1 (2.3 %) 0 (0.0 %) 0 (0.0 %)
HDR 0 (0.0 %) 0 (0.0 %) 1 (0.1 %) 1 (0.9 %) 6 (0.6 %) 3 (0.2 %) 0 (0.0 %) 1 (0.2 %) 1 (0.1 %) 1 (2.3 %) 0 (0.0 %) 1 (0.4 %)
BT-Unknown 1 (1.4 %) 8 (1.7 %) 5 (0.5 %) 0 (0.0 %) 8 (0.8 %) 6 (0.3 %) 0 (0.0 %) 1 (0.2 %) 2 (0.2 %) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %)
ADT 0 (0.0 %) 3 (0.6 %) 2 (0.2 %) 9 (8.0 %) 13 (1.2 %) 23 (1.2 %) 34 (35.1 %) 92 (14.9 %) 79 (9.1 %) 23 (52.3 %) 41 (30.8 %) 84 (34.3 %)
Chemotherapy 0 (0.0 %) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %) 1 (1.0 %) 1 (0.2 %) 1 (0.1 %) 4 (9.1 %) 5 (3.8 %) 13 (5.3 %)
Other 0 (0.0 %) 5 (1.0 %) 4 (0.4 %) 0 (0.0 %) 6 (0.6 %) 2 (0.1 %) 0 (0.0 %) 0 (0.0 %) 1 (0.1 %) 0 (0.0 %) 1 (0.8 %) 0 (0.0 %)
Not known 1 (1.4 %) 16 (3.3 %) 11 (1.2 %) 3 (2.7 %) 35 (3.3 %) 27 (1.4 %) 1 (1.0 %) 15 (2.4 %) 18 (2.1 %) 1 (2.3 %) 7 (5.3 %) 5 (2.0 %)
Total 73 (100 %) 478 (100 %) 911 (100 %) 113 (100 %) 1,064 (100 %) 1,887 (100 %) 97 (100 %) 616 (100 %) 867 (100 %) 44 (100 %) 133 (100 %) 245 (100 %)
Median (IQR) days to initial treatment N/A N/A N/A 101 (56–191) 71.5 (44–119) 61 (39–103) 57 (34–90) 49.5 (31–84.25) 43 (27–65) 27 (6–67.5) 27 (9–58.5) 19.5 (7–50)
Median (IQR) km to treating hospital 31.6 (18.9-69.3) 11.8 (6.2-25.9) 21.6 (9.1-55.5) 56.4 (23.1-114.9) 13.1 (7.2-27.4) 20.7 (10–51.4) 42.3 (19–82.7) 11.7 (6.2-25.7) 20.8 (9.8-61.3) 39.4 (19.2-80.7) 11.4 (5.5-24.7) 25.6 (11.2-71.6)
  1. *p < 0.05